共有結合修飾
WordNet
- the grammatical relation that exists when a word qualifies the meaning of the phrase (同)qualifying, limiting
- slightly modified copy; not an exact copy; "a modification of last years model"
- of or relating to or characterized by covalence; "covalent bond"
PrepTutorEJDIC
- 〈棟〉修正,変更)した(された)もの / 〈U〉〈C〉(文法で)修飾
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/10/11 21:09:56」(JST)
[Wiki en表示]
Posttranslational modification (PTM) is a step in protein biosynthesis. Proteins are created by ribosomes translating mRNA into polypeptide chains. These polypeptide chains undergo PTM (such as folding, cutting and other processes) before becoming the mature protein product.
Posttranslational modification of insulin. At the top, the ribosome translates a mRNA sequence into a protein, insulin, and passes the protein through the endoplasmic reticulum, where it is cut, folded and held in shape by disulfide (-S-S-) bonds. Then the protein passes through the golgi apparatus, where it is packaged into a vesicle. In the vesicle, more parts are cut off, and it turns into mature insulin.
A protein (also called a polypeptide) is a chain of amino acids. During protein synthesis, 20 different amino acids can be incorporated to become a protein. After translation, the posttranslational modification of amino acids extends the range of functions of the protein by attaching it to other biochemical functional groups (such as acetate, phosphate, various lipids and carbohydrates), changing the chemical nature of an amino acid (e.g. citrullination), or making structural changes (e.g. formation of disulfide bridges).
Also, enzymes may remove amino acids from the amino end of the protein, or cut the peptide chain in the middle. For instance, the peptide hormone insulin is cut twice after disulfide bonds are formed, and a propeptide is removed from the middle of the chain; the resulting protein consists of two polypeptide chains connected by disulfide bonds. Also, most nascent polypeptides start with the amino acid methionine because the "start" n mRNA also codes for this amino acid. This amino acid is usually taken off during post-translational modification.
Other modifications, like phosphorylation, are part of common mechanisms for controlling the behavior of a protein, for instance activating or inactivating an enzyme.
Post-translational modification of proteins can be detected by a variety of techniques, including mass spectrometry, Eastern blotting, and Western blotting.
Contents
- 1 PTMs involving addition of functional groups
- 1.1 PTMs involving addition by an enzyme in vivo
- 1.1.1 PTMs involving addition of hydrophobic groups for membrane localization
- 1.1.2 PTMs involving addition of cofactors for enhanced enzymatic activity
- 1.1.3 PTMs involving unique modifications of translation factors
- 1.1.4 PTMs involving addition of smaller chemical groups
- 1.2 PTMs involving non-enzymatic additions in vivo
- 1.3 PTMs involving non-enzymatic additions in vitro
- 2 PTMs involving addition of other proteins or peptides
- 3 PTMs involving changing the chemical nature of amino acids
- 4 PTMs involving structural changes
- 5 Post-translational modification statistics
- 6 Case examples
- 7 See also
- 8 External links
- 9 References
PTMs involving addition of functional groups
The genetic code diagram
[1] showing the amino acid residues as target of modification.
PTMs involving addition by an enzyme in vivo
PTMs involving addition of hydrophobic groups for membrane localization
- myristoylation, attachment of myristate, a C14 saturated acid
- palmitoylation, attachment of palmitate, a C16 saturated acid
- isoprenylation or prenylation, the addition of an isoprenoid group (e.g. farnesol and geranylgeraniol)
- farnesylation
- geranylgeranylation
- glypiation, glycosylphosphatidylinositol (GPI) anchor formation via an amide bond to C-terminal tail
PTMs involving addition of cofactors for enhanced enzymatic activity
- lipoylation, attachment of a lipoate (C8) functional group
- flavin moiety (FMN or FAD) may be covalently attached
- heme C attachment via thioether bonds with cysteins
- phosphopantetheinylation, the addition of a 4'-phosphopantetheinyl moiety from coenzyme A, as in fatty acid, polyketide, non-ribosomal peptide and leucine biosynthesis
- retinylidene Schiff base formation
PTMs involving unique modifications of translation factors
- diphthamide formation (on a histidine found in eEF2)
- ethanolamine phosphoglycerol attachment (on glutamte found in eEF1α)[2]
- hypusine formation (on conserved lysine of eIF5A (eukaryotic) and aIF5A (archeal))
PTMs involving addition of smaller chemical groups
- acylation, e.g. O-acylation (esters), N-acylation (amides), S-acylation (thioesters)
- acetylation, the addition of an acetyl group, either at the N-terminus [3] of the protein or at lysine residues.[4] See also histone acetylation.[5][6] The reverse is called deacetylation.
- formylation
- alkylation, the addition of an alkyl group, e.g. methyl, ethyl
- methylation the addition of a methyl group, usually at lysine or arginine residues. The reverse is called demethylation.
- amide bond formation
- amidation at C-terminus
- amino acid addition
- arginylation, a tRNA-mediation addition
- polyglutamylation, covalent linkage of glutamic acid residues to the N-terminus of tubulin and some other proteins.[7] (See tubulin polyglutamylase)
- polyglycylation, covalent linkage of one to more than 40 glycine residues to the tubulin C-terminal tail
- butyrylation
- gamma-carboxylation dependent on Vitamin K[8]
- glycosylation, the addition of a glycosyl group to either arginine, asparagine, cysteine, hydroxylysine, serine, threonine, tyrosine, or tryptophan resulting in a glycoprotein. Distinct from glycation, which is regarded as a nonenzymatic attachment of sugars.
- polysialylation, addition of polysialic acid, PSA, to NCAM
- malonylation
- hydroxylation
- iodination (e.g. of thyroglobulin)
- nucleotide addition such as ADP-ribosylation
- oxidation
- phosphate ester (O-linked) or phosphoramidate (N-linked) formation
- phosphorylation, the addition of a phosphate group, usually to serine, threonine, and tyrosine (O-linked), or histidine (N-linked)
- adenylylation, the addition of an adenylyl moiety, usually to tyrosine (O-linked), or histidine and lysine (N-linked)
- propionylation
- pyroglutamate formation
- S-glutathionylation
- S-nitrosylation
- succinylation addition of a succinyl group to lysine
- sulfation, the addition of a sulfate group to a tyrosine.
PTMs involving non-enzymatic additions in vivo
- glycation, the addition of a sugar molecule to a protein without the controlling action of an enzyme.
PTMs involving non-enzymatic additions in vitro
- biotinylation, acylation of conserved lysine residues with a biotin appendage
- pegylation
PTMs involving addition of other proteins or peptides
- ISGylation, the covalent linkage to the ISG15 protein (Interferon-Stimulated Gene 15)[9]
- SUMOylation, the covalent linkage to the SUMO protein (Small Ubiquitin-related MOdifier)[10]
- ubiquitination, the covalent linkage to the protein ubiquitin.
- Neddylation, the covalent linkage to Nedd
- Pupylation, the covalent linkage to the Prokaryotic ubiquitin-like protein
PTMs involving changing the chemical nature of amino acids
- citrullination, or deimination, the conversion of arginine to citrulline
- deamidation, the conversion of glutamine to glutamic acid or asparagine to aspartic acid
- eliminylation, the conversion to an alkene by beta-elimination of phosphothreonine and phosphoserine, or dehydration of threonine and serine, as well as by decarboxylation of cysteine [11]
- carbamylation, the conversion of lysine to homocitrulline [12]
PTMs involving structural changes
- disulfide bridges, the covalent linkage of two cysteine amino acids
- proteolytic cleavage, cleavage of a protein at a peptide bond
- racemization
- of proline by prolyl isomerase
- of serine by protein-serine epimerase
- of alanine in dermorphin, a frog opioid peptide
- of methionine in deltorphin, also a frog opioid peptide
Post-translational modification statistics
Recently, statistics of each post-translational modification experimentally and putatively detected have been compiled using proteome-wide information from the Swiss-Prot database.[13] These statistics can be found at http://selene.princeton.edu/PTMCuration/.
Case examples
- Cleavage and formation of disulfide bridges during the production of insulin
- PTM of histones as regulation of transcription: RNA polymerase control by chromatin structure
- PTM of RNA polymerase II as regulation of transcription
- Cleavage of polypeptide chains as crucial for lectin specificity
See also
External links
- dbPTM - database of protein post-translational modifications
- List of posttranslational modifications in ExPASy
- Browse SCOP domains by PTM — from the dcGO database
- Statistics of each post-translational modification from the Swiss-Prot database
- AutoMotif Server - A Computational Protocol for Identification of Post-Translational Modifications in Protein Sequences
- Functional analyses for site-specific phosphorylation of a target protein in cells
- Detection of Post-Translational Modifications after high-accuracy MSMS
References
- ^ Gramatikoff K. in Abgent Catalog (2004-5) p.263
- ^ Whiteheart SW, Shenbagamurthi P, Chen L, et al. (1989). "Murine elongation factor 1 alpha (EF-1 alpha) is posttranslationally modified by novel amide-linked ethanolamine-phosphoglycerol moieties. Addition of ethanolamine-phosphoglycerol to specific glutamic acid residues on EF-1 alpha.". J. Biol. Chem. 264 (24): 14334–41. PMID 2569467.
- ^ Polevoda B, Sherman F (2003). "N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins". J Mol Biol 325 (4): 595–622. doi:10.1016/S0022-2836(02)01269-X. PMID 12507466.
- ^ Yang XJ, Seto E (2008). "Lysine acetylation: codified crosstalk with other posttranslational modifications". Mol Cell 31 (4): 449–61. doi:10.1016/j.molcel.2008.07.002. PMC 2551738. PMID 18722172.
- ^ Bártová E, Krejcí J, Harnicarová A, Galiová G, Kozubek S (2008). "Histone modifications and nuclear architecture: a review". J Histochem Cytochem 56 (8): 711–21. doi:10.1369/jhc.2008.951251. PMC 2443610. PMID 18474937.
- ^ Glozak MA, Sengupta N, Zhang X, Seto E (2005). "Acetylation and deacetylation of non-histone proteins". Gene 363: 15–23. doi:10.1016/j.gene.2005.09.010. PMID 16289629.
- ^ Eddé B, Rossier J, Le Caer JP, Desbruyères E, Gros F, Denoulet P (1990). "Posttranslational glutamylation of alpha-tubulin". Science 247 (4938): 83–5. Bibcode:1990Sci...247...83E. doi:10.1126/science.1967194. PMID 1967194.
- ^ Walker CS, Shetty RP, Clark K, et al. (2001). "On a potential global role for vitamin K-dependent gamma-carboxylation in animal systems. Animals can experience subvaginalhemototitis as a result of this linkage. Evidence for a gamma-glutamyl carboxylase in Drosophila". J. Biol. Chem. 276 (11): 7769–74. doi:10.1074/jbc.M009576200. PMID 11110799.
- ^ Malakhova, Oxana A.; Yan, Ming; Malakhov, Michael P.; Yuan, Youzhong; Ritchie, Kenneth J.; Kim, Keun Il; Peterson, Luke F.; Shuai, Ke; and Dong-Er Zhang (2003). "Protein ISGylation modulates the JAK-STAT signaling pathway". Genes & Development 17 (4): 455–60. doi:10.1101/gad.1056303. PMC 195994. PMID 12600939.
- ^ Van G. Wilson (Ed.) (2004). Sumoylation: Molecular Biology and Biochemistry. Horizon Bioscience. ISBN 0-9545232-8-8.
- ^ Brennan DF, Barford D (2009). "Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases". Trends in Biochemical Sciences 34 (3): 108–114. doi:10.1016/j.tibs.2008.11.005. PMID 19233656.
- ^ Mydel P, et al. (2010). "Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis". Journal of Immunology 184 (12): 6882–6890. doi:10.4049/jimmunol.1000075. PMC 2925534. PMID 20488785.
- ^ Khoury, George A.; Baliban, Richard C.; and Christodoulos A. Floudas (2011). "Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database". Scientific Reports 1 (90). Bibcode:2011NatSR...1E..90K. doi:10.1038/srep00090.
Proteins
|
|
Processes |
- Protein biosynthesis
- Posttranslational modification
- Protein folding
- Protein targeting
- Proteome
- Protein methods
|
|
Structures |
- Protein structure
- Protein structural domains
- Proteasome
|
|
Types |
- List of types of proteins
- List of proteins
- Membrane protein
- Globular protein
- Fibrous protein
|
|
- Biochemical families: carbohydrates
- alcohols
- glycoproteins
- glycosides
- lipids
- eicosanoids
- fatty acids / intermediates
- glycerides
- phospholipids
- sphingolipids
- steroids
- nucleic acids
- constituents / intermediates
- proteins
- Amino acids / intermediates
- tetrapyrroles / intermediates
B proteins: BY STRUCTURE: membrane, globular (en, ca, an), fibrous
|
|
Protein primary structure and posttranslational modifications
|
|
General |
- Peptide bond
- Protein biosynthesis
- Proteolysis
- Racemization
- N-O acyl shift
|
|
N terminus |
- Acetylation
- Carbamylation
- Formylation
- Glycation
- Methylation
- Myristoylation (Gly)
|
|
C terminus |
- Amidation
- Glycosyl phosphatidylinositol (GPI)
- O-methylation
- Detyrosination
|
|
Single specific AAs |
Serine/Threonine
|
- Phosphorylation
- Dephosphorylation
- Glycosylation
- Methylidene-imidazolone (MIO) formation
|
|
Tyrosine
|
- Phosphorylation
- Dephosphorylation
- Sulfation
- Porphyrin ring linkage
- Adenylylation
- Flavin linkage
- Topaquinone (TPQ) formation
- Detyrosination
|
|
Cysteine
|
- Palmitoylation
- Prenylation
|
|
Aspartate
|
|
|
Glutamate
|
- Carboxylation
- Methylation
- Polyglutamylation
- Polyglycylation
|
|
Asparagine
|
- Deamidation
- Glycosylation
|
|
Glutamine
|
|
|
Lysine
|
- Methylation
- Acetylation
- Acylation
- Adenylylation
- Hydroxylation
- Ubiquitination
- Sumoylation
- ADP-ribosylation
- Deamination
- Oxidative deamination to aldehyde
- O-glycosylation
- Imine formation
- Glycation
- Carbamylation
|
|
Arginine
|
- Citrullination
- Methylation
- ADP-ribosylation
|
|
Proline
|
|
|
Histidine
|
- Diphthamide formation
- Adenylylation
|
|
Tryptophan
|
|
|
|
Crosslinks between two AAs |
Cysteine-Cysteine
|
|
|
Methionine-Hydroxylysine
|
|
|
Lysine-Tyrosylquinone
|
- Lysine tyrosylquinone (LTQ) formation
|
|
Tryptophan-Tryptophylquinone
|
- Tryptophan tryptophylquinone (TTQ) formation
|
|
|
Three consecutive AAs
(chromophore formation) |
Serine–Tyrosine–Glycine
|
- p-Hydroxybenzylidene-imidazolinone formation
|
|
Histidine–Tyrosine–Glycine
|
- 4-(p-hydroxybenzylidene)-5-imidazolinone formation
|
|
|
Crosslinks between four AAs |
Allysine-Allysine-Allysine-Lysine
|
|
|
|
←Amino acids
Secondary structure→
|
|
Gene expression
|
|
Introduction to genetics |
|
|
General flow: |
|
|
Special transfers: |
- RNA → RNA
- RNA → DNA
- Protein → Protein
|
|
|
Transcription |
- Bacterial / Archaeal / Eukaryotic
|
|
- Transcription factors
- RNA polymerase
- promoter
|
|
Post-transcriptional modification |
- hnRNA
- 5' capping
- Splicing
- Polyadenylation
- Histone acetylation and deacetylation
|
|
|
Translation |
- Prokaryotic / Archaeal / Eukaryotic
|
|
- Ribosome, tRNA, Ribosome-nascent chain complex (RNC)
|
|
- post-translational modification (functional groups, peptides, structural changes)
|
|
|
Gene regulation |
|
|
- transcriptional regulation
|
|
- post-transcriptional regulation (sequestration, alternative splicing, microRNA)
|
|
|
|
- post-translational regulation (reversible, irreversible)
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Reduction of protein adsorption and macrophage and astrocyte adhesion on ventricular catheters by polyethylene glycol and N-acetyl-L-cysteine.
- Harris CA, Resau JH, Hudson EA, West RA, Moon C, Black AD, McAllister JP 2nd.SourceDepartment of Neurosurgery and Division of Pediatric Neurosurgery University of Utah, Salt Lake City, Utah 84132; Department of Bioengineering, University of Utah, Salt Lake City, Utah 84112. carolyn.harris@hsc.utah.edu.
- Journal of biomedical materials research. Part A.J Biomed Mater Res A.2011 Sep 1;98(3):425-33. doi: 10.1002/jbm.a.33130. Epub 2011 May 31.
- Cellular obstruction of poly(dimethyl)siloxane (PDMS) catheters is one of the most prevalent causes of shunt failure in the treatment of hydrocephalus. By modifying PDMS using short- and long-chain mono-functional polyethylene glycol (PEG604 and PEG5K, respectively) and N-acetyl-L-cysteine via adsor
- PMID 21630435
Japanese Journal
- Human Serum Albumin as an Antioxidant in the Oxidation of (?)-Epigallocatechin Gallate: Participation of Reversible Covalent Binding for Interaction and Stabilization
- ISHII Takeshi,ICHIKAWA Tatsuya,MINODA Kanako,KUSAKA Koji,ITO Sohei,SUZUKI Yukiko,AKAGAWA Mitsugu,MOCHIZUKI Kazuki,GODA Toshinao,NAKAYAMA Tsutomu
- Bioscience, Biotechnology, and Biochemistry 75(1), 100-106, 2011
- … These results suggest the reversible covalent modification of EGCg via Schiff-base formation, and that the immobilization of EGCg to HSA, through the formation of a stable complex, prevented the polymerization and decomposition of EGCg in human serum. …
- NAID 130000406541
Related Links
- Definition of covalent modification in the Medical Dictionary. covalent modification explanation. Information about covalent modification in Free online English dictionary. What is covalent modification? Meaning of covalent Bing ...
- Enzyme Regulation (Part 1 of 5) - How [and which] Enzymes are Regulated, Enzyme Regulation (Part 4 of 5) - Covalent Modification - Reversible, Enzyme Regulation (Part 5 of 5) Covalent Modification - Irreversible
Related Pictures
★リンクテーブル★
[★]
- 英
- covalent modification
- 関
- 共有結合
[★]
不可逆的共有結合修飾
[★]
不可逆的共有結合修飾
[★]
可逆的共有結合修飾
[★]
可逆的共有結合修飾
[★]
- 関
- alter、alteration、amend、amendment、change、metamorphic、metamorphosis、metamorphotic、modify、revise、revision
[★]
- 関
- covalency、covalent attachment、covalent binding、covalent bond、covalently